You just read:

MYR Pharmaceuticals Announces Presentation of Final Results of the MYR203 Study of bulevirtide (Myrcludex) at the International Liver Congress (ILC) 2019 in Vienna.

News provided by

MYR Pharmaceuticals

Apr 04, 2019, 11:28 ET